Dr Avi Roy
Advisor
Biomedical scientist and longevity investor. Helps pressure-test the science and open doors with the right researchers, clinicians, and capital.
We invest in companies that make humans live longer. Healthspan Ventures backs founders in biotech, diagnostics, longevity, and human performance, and helps them get the work seen.

We look for the specific thing that makes your company possible right now: a new model, a new dataset, a new test, a regulatory window, or a new way to reach the right people.
New tools for old problems
Better data, better tests
Faster paths to proof
New routes to the right market
We are an early-stage deep-tech fund investing at pre-seed and seed. We look for founders with a real edge: a new approach, a new dataset, a new test, or a new route to market that didn't exist five years ago.
Drug discovery in software. Years cut from the path to the clinic.
Reprogramming cells. Clearing senescence. Repairing the engine of aging.
Catching disease before it is a disease. Biology read in real time.
Replacing what wears out. Rebuilding what is lost.
Months of bench work compressed into days. Labs that run themselves.
Sharper minds. Deeper sleep. A longer prime.
We do design, branding, storytelling, sales, growth, and mentorship. Then we put you in front of the right people in science, clinics, and capital.
We pressure-test the science with you. You leave clearer about what to prove first.
A wordmark, a deck, a site that match the seriousness of the work.
How to talk about the work to scientists, customers, and the next investor.
Pricing, channels, and partnerships. Operators in your corner who have shipped.
Founders need someone to call when it matters. We pick up.
Fundraising materials and a narrative that hold up when you raise the next round.
Senior scientists and operators we lean on. They sit on calls, read decks, and open doors when it matters.
Advisor
Biomedical scientist and longevity investor. Helps pressure-test the science and open doors with the right researchers, clinicians, and capital.